Stockreport

Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]

Lexeo Therapeutics, Inc.  (LXEO) 
PDF stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced that it has commenced an underwritten public offerin [Read more]